| Literature DB >> 35069112 |
Xiaopeng Liu1,2, Vipendra Kumar1, Nien-Pei Tsai1, Benjamin D Auerbach1,2.
Abstract
Fragile X Syndrome (FXS) is a leading inherited cause of autism and intellectual disability, resulting from a mutation in the FMR1 gene and subsequent loss of its protein product FMRP. Despite this simple genetic origin, FXS is a phenotypically complex disorder with a range of physical and neurocognitive disruptions. While numerous molecular and cellular pathways are affected by FMRP loss, there is growing evidence that circuit hyperexcitability may be a common convergence point that can account for many of the wide-ranging phenotypes seen in FXS. The mechanisms for hyperexcitability in FXS include alterations to excitatory synaptic function and connectivity, reduced inhibitory neuron activity, as well as changes to ion channel expression and conductance. However, understanding the impact of FMR1 mutation on circuit function is complicated by the inherent plasticity in neural circuits, which display an array of homeostatic mechanisms to maintain activity near set levels. FMRP is also an important regulator of activity-dependent plasticity in the brain, meaning that dysregulated plasticity can be both a cause and consequence of hyperexcitable networks in FXS. This makes it difficult to separate the direct effects of FMR1 mutation from the myriad and pleiotropic compensatory changes associated with it, both of which are likely to contribute to FXS pathophysiology. Here we will: (1) review evidence for hyperexcitability and homeostatic plasticity phenotypes in FXS models, focusing on similarities/differences across brain regions, cell-types, and developmental time points; (2) examine how excitability and plasticity disruptions interact with each other to ultimately contribute to circuit dysfunction in FXS; and (3) discuss how these synaptic and circuit deficits contribute to disease-relevant behavioral phenotypes like epilepsy and sensory hypersensitivity. Through this discussion of where the current field stands, we aim to introduce perspectives moving forward in FXS research.Entities:
Keywords: E/I balance; circuit hyperexcitability; epilepsy; fragile X syndrome; homeostatic plasticity; sensory hypersensitivity
Year: 2022 PMID: 35069112 PMCID: PMC8770333 DOI: 10.3389/fnmol.2021.805929
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
Figure 1Neuronal and circuit hyperexcitability in Fragile X Syndrome (FXS). Hyperexcitability owing to loss of function of the FMR1 gene and its protein product FMRP manifests across levels of the CNS via a variety of mechanisms. (A) Several lines of evidence indicate that disrupted excitatory/inhibitory synaptic balance due to altered activity-dependent refinement of synaptic connectivity and impaired synaptic transmission and plasticity contribute to circuit hyperexcitability in FXS. In particular, there is evidence for a reduction in inhibitory synaptic transmission in several brain regions of FMR1 KO animals which, in addition to excessive excitatory connectivity in some cases, can result in increased E/I ratio and circuit hyperexcitability. (B) FMRP deficiency is also associated with dysregulated ion channel function and expression, resulting in changes to intrinsic excitability, action potential (AP) slope and duration, and increased the axon initial segment (AIS) length in some brain areas. AIS is enriched in many of the ion channels that are directly or indirectly regulated by FMRP. (C) Hyperexcitability in FXS can also arise from impaired homeostatic plasticity, which is an essential mechanism for maintaining basal network activity and preventing circuit hypo- or hyperexcitability. For instance, FMR1 KO neurons exhibit dysregulated homeostatic changes to intrinsic excitability in response to activity blockade, resulting in increased AP slope and cellular hyperexcitability compared to WT neurons.